Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 50Small Cell Lung Carcinoma 23Breast Neoplasms 17Sarcoma 16Carcinoma, Hepatocellular 10Lung Neoplasms 9Esophageal Squamous Cell Carcinoma 9Stomach Neoplasms 8Neoplasms 8Triple Negative Breast Neoplasms 7Ovarian Neoplasms 7Nasopharyngeal Carcinoma 7Neoplasm Metastasis 6Pancreatic Neoplasms 5NSCLC 5Colorectal Neoplasms 5Carcinoma 5Uterine Cervical Neoplasms 4Thyroid Neoplasms 4Pheochromocytoma 4Esophageal Neoplasms 4Endometrial Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Ovarian Epithelial 4Recurrence 3Paraganglioma 3Non-squamous Non-small Cell Lung Cancer 3Glioma 3Fallopian Tube Neoplasms 3Cholangiocarcinoma 3

Interventions

Diathermy 20Radiotherapy 10Cisplatin 5Fluorouracil 4Drug Therapy 4Radiation 3Melphalan 3Immune Checkpoint Inhibitors 3Cytoreduction Surgical Procedures 3Brachytherapy 3tislelizumab 2Solutions 2Immunotherapy 2Hyperthermia, Induced 2Hydrogen Peroxide 2Doxorubicin 2Conization 2Capecitabine 2spartalizumab 1sodium thiosulfate 1anlotinib 1Temozolomide 1Surgical Procedures, Operative 1Saline Solution 1Radiation Dose Hypofractionation 1Paclitaxel 1Oxaliplatin 1Mitomycin 1Leucovorin 1Laser Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hyperthermia × anlotinib × Clear all
NCT06249750 2024-02-08

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

Zhejiang Hospital

Phase 2 Recruiting
60 enrolled

Hyperthermia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡